Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,429-1,440 of 4,306
Behavioral study icon
CompletedNCT03873337

Persistence Targeted Smoking Cessation in Serious Mental Illness (SMI)

This summary needs review. Please check the official study record and contact the research team for details.

In New Brunswick
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, AddictionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
Rutgers, The State University of New Jersey
Condition
Schizophrenia, Addiction
Drug study icon
WithdrawnNCT05974527

Sublingual Dexmedetomidine for Schizophrenia

This study was withdrawn. It is testing sublingual Dexmedetomidine for Schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugA study involving a medication or substance.Over 18 Years
Countries
Sponsor
Brigham and Women's Hospital
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00793780

study of Naltrexone for Obesity in Women With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New Haven
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Yale University
Condition
Schizophrenia
Drug study icon
CompletedNCT00918021

Polypharmacy in Clozapine-resistant Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Kuopio
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
Finland
Sponsor
Niuvanniemi Hospital
Condition
Schizophrenia
Drug study icon
CompletedNCT00728728

Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Durham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Drug study icon
CompletedNCT02074319

RCT of Methotrexate Added to Treatment As Usual in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Karachi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 35 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02869334

Remediation of Auditory Recognition in Schizophrenia With tDCS

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00995553

Remediation of Working Memory in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 60 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.